Snapshot - Kymera Therapeutics, Inc. (NASDAQ: KYMR)
What's happening inside: Kymera closed a large follow‑on equity raise in June 2025 (initial close $250.8M; underwriters later exercised options bringing total primary proceeds to ~$288.4M) and announced a $40M option/licensing upfront from Gilea...